Results 31 to 40 of about 694,618 (154)

Pressurized Intraperitoneal Aerosol Chemotherapy-Related Clinical Trials in the Treatment of Peritoneal Metastases. [PDF]

, 2021
INTRODUCTION Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a treatment option for patients with peritoneal metastases. We evaluated the current status of ongoing prospective clinical trials investigating PIPAC to provide an overview and ...
Putora, Paul Martin, Cihoric, Nikola, Ukegjini, Kristjan, Steffen, Thomas, Widmann, Bernhard, Guidi, Marisa, Süveg, Krisztian, Kristjan Ukegjini, Marisa Guidi, Thomas Steffen, Bernhard Widmann, Nikola Cihoric, Krisztian Süveg, Paul Martin Putora   +13 more
core   +1 more source

Body composition and immunonutritional status in patients treated with pressurized intraperitoneal aerosol chemotherapy (PIPAC) for gastrointestinal peritoneal metastases: a prospective single-center analysis

Pleura and Peritoneum, 2022
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is a novel drug administration method with promising efficacy for the treatment of peritoneal metastases (PM).
Rotolo Stefano, Di Giorgio Andrea, Cintoni Marco, Rinninella Emanuele, Palombaro Marta, Pulcini Gabriele, Schena Carlo Alberto, Chiantera Vito, Vizzielli Giuseppe, Gasbarrini Antonio, Pacelli Fabio, Mele Maria Cristina   +11 more
doaj   +1 more source

Advances in Treatment Models of Advanced Gastric Cancer

Technology in Cancer Research & Treatment, 2022
The prognosis of advanced gastric cancer (AGC) is extremely poor, and the therapeutic effect of traditional palliative chemotherapy is far from satisfactory.
Tao Li, Yufang He, Qinglei Zhong, Jiang Yu, Xinhua Chen   +4 more
doaj   +1 more source

A systematic review on quality of life (QoL) of patients with peritoneal metastasis (PM) who underwent pressurized intraperitoneal aerosol chemotherapy (PIPAC)

Pleura and Peritoneum, 2022
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) has recently emerged as a palliative alternative for patients with unresectable peritoneal metastasis (PM).
Li Zhenyue, Wong Louis Choon Kit, Sultana Rehena, Lim Hui Jun, Tan Joey Wee-Shan, Tan Qiu Xuan, Wong Jolene Si Min, Chia Claramae Shulyn, Ong Chin-Ann Johnny   +8 more
doaj   +1 more source

Oxaliplatin-induced peripheral neurotoxicity in colorectal cancer patients: mechanisms, pharmacokinetics and strategies

Frontiers in Pharmacology, 2023
Oxaliplatin-based chemotherapy is a standard treatment approach for colorectal cancer (CRC). However, oxaliplatin-induced peripheral neurotoxicity (OIPN) is a severe dose-limiting clinical problem that might lead to treatment interruption.
Fang Cheng, Ruoqi Zhang, Chen Sun, Qian Ran, Cuihan Zhang, Changhong Shen, Ziqing Yao, Miao Wang, Lin Song, Cheng Peng   +9 more
doaj   +1 more source

Gastric Cancer With Peritoneal Metastasis—A Comprehensive Review of Current Intraperitoneal Treatment Modalities

Frontiers in Oncology, 2022
The treatment of patients with peritoneal metastasis from gastric cancer continues to evolve. With various forms of intraperitoneal drug delivery available, it is now possible to reach the sites of peritoneal metastases, which were otherwise sub ...
Aruna Prabhu, Deepti Mishra, Andreas Brandl, Andreas Brandl, Yutaka Yonemura, Yutaka Yonemura, Yutaka Yonemura   +6 more
doaj   +1 more source

Reasons for stopping PIPAC.

, 2023
* PIPAC = Pressurized IntraPeritoneal Aerosol Chemotherapy. CRS/HIPEC = CytoReductive Surgery/Hyperthermic IntraPeritoneal Chemotherapy.
Pierre-Louis Conan (17511346), Adeline Aime (17511349), Hugo Picchi (17511355), Solène Doat (15006081), Marc Pocard (3795094), Jade Fawaz (17511352), Brice Malgras (17511343), Anne-Cécile Ezanno (17511340)   +7 more
core   +1 more source

Systemic chemotherapy and pressurized intraperitoneal aerosol chemotherapy (PIPAC): A case report of a multimodal treatment for peritoneal metastases of pancreatic origin [PDF]

, 2020
Introduction: Pancreatic ductal adenocarcinoma (PDAC) with peritoneal metastases (PM) has a dismal prognosis and palliative systemic chemotherapy, which represents the standard treatment option, has significant pharmacokinetics limitations and low ...
Ferracci F., Inzani F., Abatini C., Di Giorgio A., Santullo F., Pacelli F., Lodoli C., Rotolo S.   +7 more
core   +2 more sources

Occupational Exposure during Intraperitoneal Pressurized Aerosol Chemotherapy Using Doxorubicin in a Pig Model

Safety and Health at Work, 2023
Background: This study evaluated occupational exposure levels of doxorubicin in healthcare workers performing rotational intraperitoneal pressurized aerosol chemotherapy (PIPAC) procedures.
Wongeon Jung, Mijin Park, Soo Jin Park, Eun Ji Lee, Hee Seung Kim, Sun Ho Chung, Chungsik Yoon   +6 more
doaj   +1 more source

Pressurized Intraperitoneal Aerosol Chemotherapy: The Road from Promise to Proof

, 2021
Pressurized intraperitoneal aerosol chemotherapy (PIPAC) is an innovative drug delivery technique invented to be used for the treatment of peritoneal metastasis. Its application gained popularity over the past years.
Erp, N.P. van, Jong, L.A.W. de, Bijelic, L., Loek A.W. de Jong, Nielka P. van Erp, Lana Bijelic   +5 more
core   +1 more source